Peng F - Search Results

1

A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC.

Huang M, Gong Y, Zhu J, Qin Y, Peng F, Ren L, Ding Z, Liu Y, Cai C, Wang Y, Lu Y. Huang M, et al. Among authors: peng f. Invest New Drugs. 2020 Apr;38(2):478-484. doi: 10.1007/s10637-019-00811-6. Epub 2019 Jun 24. Invest New Drugs. 2020. PMID: 31231786 Clinical Trial.

2

[Fourth-line and beyond therapy in advanced non-small cell lung cancer: a retrospective analysis].

Wang X, Huang M, Ren L, Xu Y, Li L, Hou M, Wang J, Peng F, Zhu J, Wang Y, Lu Y. Wang X, et al. Among authors: peng f. Zhongguo Fei Ai Za Zhi. 2014 Dec;17(12):839-44. doi: 10.3779/j.issn.1009-3419.2014.12.03. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25539608 Free PMC article. Chinese.

3

Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer.

Zhou M, Li T, Liu Y, Sun C, Li N, Xu Y, Zhu J, Ding Z, Wang Y, Huang M, Peng F, Wang J, Ren L, Lu Y, Gong Y. Zhou M, et al. Among authors: peng f. BMC Cancer. 2015 Feb 6;15:36. doi: 10.1186/s12885-015-1036-0. BMC Cancer. 2015. PMID: 25655307 Free PMC article.

4

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports.

Liu Y, Zhang Y, Zhang L, Liu B, Wang Y, Zhou X, Li Y, Zhao Q, Gong Y, Zhou L, Zhu J, Ding Z, Wang J, Peng F, Huang M, Li L, Ren L, Lu Y. Liu Y, et al. Among authors: peng f. Oncotarget. 2017 Jul 25;8(30):49680-49688. doi: 10.18632/oncotarget.17915. Oncotarget. 2017. PMID: 28591695 Free PMC article.

5

Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.

Yu M, Zhao Q, Li Y, Zhang S, Xu Y, Gong Y, Zhu J, Ding Z, Wang J, Peng F, Wang Y, Huang M, Ren L, Lu Y, Liu Y. Yu M, et al. Among authors: peng f. Cancer Biother Radiopharm. 2018 Dec;33(10):421-426. doi: 10.1089/cbr.2018.2493. Cancer Biother Radiopharm. 2018. PMID: 31050549

6

Crizotinib versus chemotherapy: a real-world cost-effectiveness study in China.

Huang M, Tian Y, He M, Liu J, Ren L, Gong Y, Peng F, Wang Y, Ding Z, Wang J, Zhu J, Xu Y, Liu Y, Li L, Lu Y. Huang M, et al. Among authors: peng f. J Comp Eff Res. 2020 Jan;9(2):93-102. doi: 10.2217/cer-2019-0075. Epub 2020 Jan 21. J Comp Eff Res. 2020. PMID: 31958984 Free article.

7

PD-L1 expression is a promising predictor of survival in patients with advanced lung adenocarcinoma undergoing pemetrexed maintenance therapy.

Qin Y, Jiang L, Yu M, Li Y, Zhou X, Wang Y, Gong Y, Peng F, Zhu J, Liu Y, Xu Y, Zhou L, Lu Y, Huang M. Qin Y, et al. Among authors: peng f. Sci Rep. 2020 Sep 30;10(1):16150. doi: 10.1038/s41598-020-73013-3. Sci Rep. 2020. PMID: 32999345 Free PMC article.

8

Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients.

Cai C, Tang Y, Li Y, Chen Y, Tian P, Wang Y, Gong Y, Peng F, Zhang Y, Yu M, Wang K, Zhu J, Lu Y, Huang M. Cai C, et al. Among authors: peng f. Lung Cancer. 2021 Feb;152:104-108. doi: 10.1016/j.lungcan.2020.12.018. Epub 2021 Jan 9. Lung Cancer. 2021. PMID: 33444901

9

Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study.

Wei H, Zhou X, Yang H, Gong Y, Wang J, Xu Y, Zhou L, Xue J, Zou B, Zhang Y, Zhu J, Peng F, Huang M, Lu Y, Liu Y. Wei H, et al. Among authors: peng f. J Cancer Res Clin Oncol. 2022 Oct;148(10):2589-2598. doi: 10.1007/s00432-021-03831-z. Epub 2021 Oct 20. J Cancer Res Clin Oncol. 2022. PMID: 34669037

10

[Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancer using bi-loop probe specific primer quantitative PCR].

Wang LS, Zhang Y, Lu XJ, Lu HJ, Zhou L, Wang YS, Deng L, Huang MJ, Peng F, Wang J, Ren L, Hou M, Li L, Xu Y, Ying BW, Lu Y. Wang LS, et al. Among authors: peng f. Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):667-70. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22321544 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,526 results

Search Page

Filters